Reflection of successful anticancer drug development processes in the literature.

Heinemann, Fabian; Huber, Torsten; Meisel, Christian; Bundschus, Markus; Leser, Ulf

Heinemann, Fabian; Huber, Torsten; Meisel, Christian; Bundschus, Markus; Leser, Ulf.

Affiliation

Heinemann F; Roche Diagnostics, Scientific Information Services, Nonnenwald 2, 82377 Penzberg, Germany. Electronic address: fabian.heinemann@roche.com.
Huber T; Humboldt-Universität zu Berlin, Wissensmanagement in der Bioinformatik, Rudower Chaussee 25, 12489 Berlin, Germany.
Meisel C; Roche Innovation Center Munich, Roche Pharma Research and Early Development, Roche Diagnostics, Nonnenwald 2, 82377 Penzberg, Germany.
Bundschus M; Roche Diagnostics, Scientific Information Services, Nonnenwald 2, 82377 Penzberg, Germany.
Leser U; Humboldt-Universität zu Berlin, Wissensmanagement in der Bioinformatik, Rudower Chaussee 25, 12489 Berlin, Germany.

Drug Discov Today ; 21(11): 1740-1744, 2016 11.

Article in En | MEDLINE | ID: mdl-27443674

Subject(s)

Antineoplastic Agents; Drug Approval/statistics & numerical data; Drug Discovery; Publishing/statistics & numerical data; Biomedical Research; Machine Learning

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Publishing / Drug Approval / Drug Discovery / Antineoplastic Agents Type of study: Prognostic_studies Language: En Journal: Drug Discov Today Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2016 Document type: Article Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google